No Data
No Data
News On Eliem Therapeutics Inc. (ELYM) Now Under CLYM
Express News | Eliem Therapeutics Inc: Climb Bio Will Begin Trading on Nasdaq Under Trading Symbol "Clym" Effective October 3
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
Insiders Could Have Profited By Holding Onto Eliem Therapeutics Shares Despite 41% Drop
Private Equity Firms Who Have a Significant Stake Must Be Disappointed Along With Institutions After Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) Market Cap Dropped by US$231m
Top Premarket Gainers